Mannkind (MNKD) Operating Margin Growth (3y) (2019 - 2026)

Mannkind (MNKD) Operating Margin Growth (3y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,942.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 530.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -1,211.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -623.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Mannkind 1.20 Bn 1.07 Bn 82.66 Mn 1,292.00

Historic Data

Download Data
DateValue
Mar 31, 2026 1,292.00
Dec 31, 2025 2,860.00
Sep 30, 2025 5,228.00
Jun 30, 2025 11,518.00
Mar 31, 2025 20,570.00
Dec 31, 2024 22,602.00
Sep 30, 2024 4,788.00
Jun 30, 2024 6,707.00
Mar 31, 2024 6,074.00
Dec 31, 2023 14,220.00
Sep 30, 2023 6,942.00
Jun 30, 2023 396,104.00
Mar 31, 2023 2,910.00
Dec 31, 2022 3,551.00
Sep 30, 2022 122,487.00
Jun 30, 2022 536,774.00
Mar 31, 2022 -9,980.00
Dec 31, 2021 -14,330.00
Sep 30, 2021 45,238.00
Jun 30, 2021 48,341.00